, Deep Mukherjee
| New Delhi |
Published: June 25, 2020 4:39:41 am
A DAY AFTER Ramdev launched an ayurvedic ‘Corona Kit’ claiming it cured Covid-19, serious questions have emerged over the business practices of Patanjali Ayurved Ltd, the FMCG company that markets Patanjali brand products and Divya Pharmacy, the unit producing the medicines.
On Wednesday, a day after the Ministry of Ayush ordered Patanjali to stop publicising claims of Covid-19 cure, the Uttarakhand government said its licencing authority did not grant any approval to the Corona Kit, and the Rajasthan government told The Indian Express it had no knowledge of clinical trials at National Institute of Medical Sciences and Research (NIMS), a private hospital in Jaipur where Covid-19 patients are admitted.
Most significantly, when mildly symptomatic patients developed fever during the trials, they were administered allopathic medicines. As it is, the trials were conducted only on asymptomatic and mildly symptomatic patients. Severely symptomatic patients and those with acute respiratory distress syndrome were excluded for enrolment.
Moreover, the study based on these…